An experiment revealed that polyphyllin VI (PPVI), a bioactive ingredient extracted from the traditional Chinese medicine Paris polyphylla, increases ROS accumulation, which in turn activates ROS-regulated JNK and p38 pathways and regulates the G2/M phase to inhibit glioma cell proliferation (Liu et al., 2020). This evidence concerns the gene MAPK1 and central nervous system cancer.